Natco Pharma Ltd - Share Price
NATCOPHARM
Natco Pharma LtdFinancials
Natco Pharma LtdNews & Updates
Natco Pharma launches breast cancer treatment drug Lapatinib Tablet in US
Sep 30,2020 07:05 PM
Through its marketing partner - Lupin
Natco Pharma to hold AGM Sep 19,2020
Natco Pharma Ltd leads gainers in A group Sep 18,2020
Natco Pharma Ltd Surges 10.62%, S&P BSE Healthcare index Gains 2.28% Sep 18,2020
Natco Pharma stock ends higher after board approves hiking stake in Mauritius unit Sep 10,2020
Board of Natco Pharma recommends interim dividend Aug 13,2020
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 484.50 | 39.00 | 116,211.79 | 531.95 | 0.83 | 2,878.64 | 101.68 |
| Dr Reddys Laboratories Ltd | 5,018.25 | 24.97 | 83,399.01 | 950.20 | 0.50 | 3,244.40 | 919.75 |
| Divis Laboratories Ltd | 3,068.85 | 50.97 | 81,425.85 | 492.25 | 0.52 | 1,709.96 | 275.61 |
| Cipla Ltd | 757.55 | 27.31 | 61,029.79 | 610.30 | 0.53 | 3,035.72 | 215.82 |
| Biocon Ltd | 417.20 | 146.90 | 50,064.00 | 95.00 | 0.00 | 560.00 | 64.73 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Natco Pharma LtdSummary & Reports
No Company Summary found
Registered Office
Natco House,Road No 2 Banjara Hills,Hyderabad, Telangana,500033
Tell. : +91-040-23547532
Website : http://www.natcopharma.co.in
Email : investors@natcopharma.co.in
Registrar Office
12-10-167, Bharath Nagar, Hyderbad - 500018 INDIA
Tell. : +91-040-23818475/76/2
Website : www.vccilindia.com
Email : info@vccilindia.com
Reports by natco-pharma-ltd
Latest Release by natco-pharma-ltd
Result Express
Natco Pharma Ltd's Q2FY19 consolidated net profit rises 115.17% yoy to Rs181.60cr : Misses Estimates
Oct 24, 2020 05:17 AM
The company’s consolidated revenue stood at Rs543.50cr, up 27.37% yoy and 0.91% qoq.
Shareholding Snapshot
Loading ...
| Sep - 2020 | |
|---|---|
| Promoter | - |
| Foreign | 0.00% |
| Indian | 48.91% |
| Total Promoter | 48.91% |
| Non Promoter | - |
| Institutions | 33.03% |
| Non-Institutions | 18.07% |
| Total Non-Promoter | 51.09% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
AGM
Exp. Date
15 Oct 2020
Annc. Date
18 Sep 2020
AGM 15/10/2020Notice of 37th Annual General Meeting for the financial year 2019-20Paper notice publi... More
Purpose
Board Meeting
Exp. Date
10 Sep 2020
Annc. Date
10 Sep 2020
outcome of the Board Meeting held on 10th September, 2020... More
Purpose
Dividend
Annc. Date
12 Aug 2020
Effective. Date
21 Aug 2020
Divi. Type
Interim
Divi.(%)
62.5
Divi. Amt.
1.25
Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on ... More
Purpose
Board Meeting
Exp. Date
12 Aug 2020
Annc. Date
03 Aug 2020
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is sched... More
